Skip to content
HeLa S3
Tissue
Cervix
Disease
Adenocarcinoma
Synonyms
HeLa s3, HeLa-S3, HELA-S3, HeLa/S3, HeLa.S3, HeLa S 3, HeLa S-3, HeLaS3, S3-HeLa, S3 HeLa

Documents

HeLa S3

Cell line · Product number 300384

The HeLa S3 cell line is a clonal derivative of the original HeLa cell line, which was established from the cervical cancer cells of an adult woman. HeLa ...

US$395.00excl. tax and shipping
In stock
Lot
Recommended (freshest lot)
  • CoA
1

01General information

Description

The HeLa S3 cell line is a clonal derivative of the original HeLa cell line, which was established from the cervical cancer cells of an adult woman. HeLa S3 cells are notable for their robust growth in suspension cultures and are frequently used in scientific research due to their adaptability to various medium formulations. This variant retains the key characteristics of the HeLa lineage, such as a rapid doubling time and a karyotype that is highly aneuploid, displaying numerous chromosomal abnormalities which are a hallmark of HeLa cells.

HeLa S3 cells are widely utilized in virology, toxicology, and cancer research, particularly because they maintain the ability to be infected by poliovirus and other viruses, making them invaluable in pathogen-host interaction studies. They are also employed in the study of gene expression and regulation mechanisms under physiological and pathological conditions. The genetic and metabolic profiles of HeLa S3 have been extensively characterized, facilitating their use in high-throughput genetic screens and molecular biology applications.

Tissue
Cervix
Disease
Adenocarcinoma
Synonyms
  • HeLa s3
  • HeLa-S3
  • HELA-S3
  • HeLa/S3
  • HeLa.S3
  • HeLa S 3
  • HeLa S-3
  • HeLaS3
  • S3-HeLa
  • S3 HeLa

02Classification

Organism
Human
Sex
Female
Growth properties
Adherent
Biosafety level
1

03Characteristics

Morphology
Epithelial-like

04Identifiers

Citation
HeLa S3 (Cytion catalog number 300384)
NCBI TaxID
9606
Cellosaurus
CVCL_0058

05Expression and susceptibility

Isoenzymes
G6PD, A
Virus susceptibility
Poliovirus 1, 2, 3, vesicular stomatitis (Indiana), encephalomyocarditis, adenovirus 5
Reverse transcriptase
Negative
Products
Keratin

06Handling and culture

Culture medium
EMEM (MEM Eagle), w: 2 mM L-Glutamine, w: 2.2 g/L NaHCO3, w: EBSS (Cytion article number 820100a)
Incubation atmosphere

37°C, 5% CO2, humidified atmosphere.

Supplements
Supplement the medium with 10% FBS and 1% NEAA
Dissociation reagent
Accutase
Subculturing
Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium.
Seeding density
1 x 104 cells/cm2
Fluid renewal
2 to 3 times per week
Post-thaw recovery
After thawing, plate the cells at 5 x 104 cells/cm2 and allow the cells to recover from the freezing process and to adhere for at least 24 hours.
Thawing and culturing
  1. Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.

  2. Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.

  3. For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.

  4. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.

  5. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.

  6. Centrifuge the mixture at 300 x g for 3 minutes to separate the cells and carefully discard the supernatant containing residual freezing medium.

  7. Gently resuspend the cell pellet in 10 ml of fresh culture medium. For adherent cells, divide the suspension between two T25 culture flasks; for suspension cultures, transfer all the medium into one T25 flask to promote effective cell interaction and growth.

  8. Adhere to established subculture protocols for continued growth and maintenance of the cell line, ensuring reliable experimental outcomes.

07Quality control and cryopreservation

Sterility

Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods.

To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections.

Freeze medium
As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress.
Storage conditions

For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.

Shipping conditions

Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.

08Donor

Donor age
30 years
Ethnicity
African American